GRBK vs ECG

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

GRBK

53.6
AI Score
VS
GRBK Wins

ECG

38.6
AI Score

Investment Advisor Scores

GRBK

54score
Recommendation
HOLD

ECG

39score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric GRBK ECG Winner
Forward P/E 10.627 19.2308 GRBK
PEG Ratio 1.1506 0 Tie
Revenue Growth -8.7% 33.7% ECG
Earnings Growth -8.1% 59.2% ECG
Tradestie Score 53.6/100 38.6/100 GRBK
Profit Margin 14.8% 6.0% GRBK
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY GRBK

Relative Price Performance (Last 90 Days)

GRBK 1M: -6.2% · 3M: -13.3% ECG 1M: +10.9% · 3M: -13.1%

Current Technical Phase

GRBK

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.9%), weak momentum, RSI 41

RSI (14): 40.7 · Price: $66.55

ECG

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 59

RSI (14): 59.3 · Price: $125.02

Fundamentals Snapshot

Metric GRBK ECG
Market Cap — —
Forward P/E 11.1 19.9
Trailing P/E 10.0 23.6
Revenue (TTM) — —
Revenue Growth -0.1% 0.3%
Gross Margin 0.3% 0.1%
Operating Margin 0.2% 0.1%
EPS 6.64 4.98
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, GRBK is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.